Skip to content
10-Q

Quarterly Report

Moderna, Inc. MRNA

0001682852-25-000075

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 390.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 390M sh
Shares Diluted Q3 2025 · Sep 30, 2025 388M sh
Shares Diluted Q3 2025 · Sep 30, 2024 399M sh
Shares Diluted Q3 2025 · Sep 30, 2024 383M sh
Capex Q3 2025 · Sep 30, 2025 $153M
Capex Q3 2025 · Sep 30, 2024 $529M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$2.8B
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$3.83B
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.13B
Cash And Equivalents Q3 2025 · Dec 31, 2024 $1.93B
Cash And Equivalents Q3 2025 · Sep 30, 2024 $1.64B
Stockholders Equity Q3 2025 · Sep 30, 2025 $9.33B
Stockholders Equity Q3 2025 · Jun 30, 2025 $9.4B
Stockholders Equity Q3 2025 · Dec 31, 2024 $10.9B
Stockholders Equity Q3 2025 · Sep 30, 2024 $11.93B
Stockholders Equity Q3 2025 · Jun 30, 2024 $11.71B
Stockholders Equity Q3 2025 · Dec 31, 2023 $13.85B
Current Liabilities Q3 2025 · Sep 30, 2025 $1.68B
Current Liabilities Q3 2025 · Dec 31, 2024 $2.21B
Total Liabilities Q3 2025 · Sep 30, 2025 $2.81B
Total Liabilities Q3 2025 · Dec 31, 2024 $3.24B
Current Assets Q3 2025 · Sep 30, 2025 $6.6B
Current Assets Q3 2025 · Dec 31, 2024 $8.1B
Total Assets Q3 2025 · Sep 30, 2025 $12.14B
Total Assets Q3 2025 · Dec 31, 2024 $14.14B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.51
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.15
Eps Diluted Q3 2025 · Sep 30, 2024 $0.03
Eps Diluted Q3 2025 · Sep 30, 2024 −$6.37
Eps Basic Q3 2025 · Sep 30, 2025 −$0.51
Eps Basic Q3 2025 · Sep 30, 2025 −$5.15
Eps Basic Q3 2025 · Sep 30, 2024 $0.03
Eps Basic Q3 2025 · Sep 30, 2024 −$6.37
Sga Expense Q3 2025 · Sep 30, 2025 $268M
Sga Expense Q3 2025 · Sep 30, 2025 $710M
Sga Expense Q3 2025 · Sep 30, 2024 $281M
Sga Expense Q3 2025 · Sep 30, 2024 $823M
Rd Expense Q3 2025 · Sep 30, 2025 $801M
Rd Expense Q3 2025 · Sep 30, 2025 $2.36B
Rd Expense Q3 2025 · Sep 30, 2024 $1.14B
Rd Expense Q3 2025 · Sep 30, 2024 $3.42B
Net Income Q3 2025 · Sep 30, 2025 −$200M
Net Income Q3 2025 · Sep 30, 2025 −$2B
Net Income Q3 2025 · Sep 30, 2024 $13M
Net Income Q3 2025 · Sep 30, 2024 −$2.44B
Operating Income Q3 2025 · Sep 30, 2025 −$260M
Operating Income Q3 2025 · Sep 30, 2025 −$2.22B
Operating Income Q3 2025 · Sep 30, 2024 −$70M
Operating Income Q3 2025 · Sep 30, 2024 −$2.7B
Cost Of Revenue Q3 2025 · Sep 30, 2025 $207M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $416M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $514M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $725M
Revenue Q3 2025 · Sep 30, 2025 $1.02B
Revenue Q3 2025 · Sep 30, 2025 $1.27B
Revenue Q3 2025 · Sep 30, 2024 $1.86B
Revenue Q3 2025 · Sep 30, 2024 $2.27B